NCT05873387 Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
| NCT ID | NCT05873387 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eko Devices, Inc. |
| Condition | Pulmonary Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,420 participants |
| Start Date | 2023-07-12 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,420 participants in total. It began in 2023-07-12 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential to assist the provider to suspect PH.
Eligibility Criteria
Inclusion Criteria: * Patients, ages \>18 years, referred for complete 2-dimensional echocardiography or right heart catheterization will be screened for inclusion. Exclusion Criteria: * Patients undergoing limited echocardiography * Intubated patients
Contact & Investigator
Guarav Choudhary, MD
PRINCIPAL INVESTIGATOR
Lifespan
Frequently Asked Questions
Who can join the NCT05873387 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05873387 currently recruiting?
Yes, NCT05873387 is actively recruiting participants. Contact the research team at spencer.kieu@ekohealth.com for enrollment information.
Where is the NCT05873387 trial being conducted?
This trial is being conducted at Providence, United States, Providence, United States, Providence, United States.
Who is sponsoring the NCT05873387 clinical trial?
NCT05873387 is sponsored by Eko Devices, Inc.. The principal investigator is Guarav Choudhary, MD at Lifespan. The trial plans to enroll 2,420 participants.